Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 37 (1), 85-88

Use of Fludrocortisone for Intradialytic Hypotension

Affiliations

Use of Fludrocortisone for Intradialytic Hypotension

Yuri Seo et al. Kidney Res Clin Pract.

Abstract

Intradialytic hypotension during dialysis adversely affects a patient's prognosis and increases mortality. We report a case in which intradialytic hypotension that persisted after the administration of midodrine was relieved after the use of fludrocortisone. Administration of 0.2 mg of fludrocortisone occurred 30 minutes before dialysis. We compared 45 sessions of dialysis without fludrocortisone administration and 45 sessions of dialysis with fludrocortisone administration in one patient. The number of times in which systolic blood pressure became lower than 80 mmHg and the number of early terminations of dialysis due to a decrease in systolic blood pressure were higher in the sessions without fludrocortisone administration than in the sessions with fludrocortisone administration (P < 0.05). Fludrocortisone may be helpful for the treatment of intradialytic hypotension that does not respond to midodrine administration.

Keywords: Fludrocortisone; Hypotension; Midodrine; Renal dialysis.

Conflict of interest statement

Conflicts of interest All authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–1220. doi: 10.1111/j.1523-1755.2004.00812.x. - DOI - PubMed
    1. Flythe JE, Inrig JK, Shafi T, et al. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013;61:966–974. doi: 10.1053/j.ajkd.2012.12.023. - DOI - PMC - PubMed
    1. Perazella MA. Pharmacologic options available to treat symptomatic intradialytic hypotension. Am J Kidney Dis. 2001;38(4 Suppl 4):S26–S36. doi: 10.1053/ajkd.2001.28092. - DOI - PubMed
    1. Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–860. doi: 10.1016/j.jacc.2015.06.1084. - DOI - PubMed
    1. Mercadal L, Petitclerc T. Effect of mineralocorticoids on interdialytic weight gain in hemodialysis patients with perdialytic hypotension. Hemodial Int. 2005;9:338–340. doi: 10.1111/j.1542-4758.2005.01150.x. - DOI - PubMed

LinkOut - more resources

Feedback